From smoking to lung cancer: The CHRNA5/A3/B4 connection

Oncogene

Volumn 29, Issue 35, 2010, Pages 4874-4884

  Improgo, M R D ^a   Scofield, M D ^a   Tapper, A R ^a   Gardner, P D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

CHRNA5 A3 B4 gene cluster; lung cancer; nicotine addiction; nicotinic acetylcholine receptors

Indexed keywords

NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR BETA4; UNCLASSIFIED DRUG; NICOTINE; NITROSAMINE;

CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; GENE CLUSTER; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LUNG CANCER; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO DEPENDENCE; ADDICTION; ANIMAL; CHEMISTRY; GENETICS; IMMUNOLOGY; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; SMOKING; TOXICITY;

ANIMALS; HUMANS; LUNG NEOPLASMS; NICOTINE; NITROSAMINES; RECEPTORS, NICOTINIC; SMOKING; SUBSTANCE-RELATED DISORDERS;

NICOTIANA TABACUM;

EID: 77956339015     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.256     Document Type: Review

References (43)

1. ACS (2009). Cancer Facts And Figures 2009. American Cancer Society: Atlanta, Georgia, USA, pp 1-68.
2. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. (2009). Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89: 73-120.
3. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T et al. (2008). Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40: 616-622.
4. Arneric SP, Holladay M, Williams M. (2007). Neuronal nicotinic receptors: a perspective on two decades of drug discovery research. Biochem Pharmacol 74: 1092-1101.
5. Arredondo J, Chernyavsky AI, Grando SA. (2006a). The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells. J Cancer Res Clin Oncol 132: 653-663.
6. Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA. (2006b). Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways down-stream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J 20 2093-2101.
7. Arredondo J, Nguyen VT, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA. (2001). A receptor-mediated mechanism of nicotine toxicity in oral keratinocytes. Lab Invest 81: 1653-1668.
8. Ball DW, Azzoli CG, Baylin SB, Chi D, Dou S, Donis-Keller H et al. (1993). Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci USA 90: 5648-5652.
9. Battaglioli E, Gotti C, Terzano S, Flora A, Clementi F, Fornasari D. (1998). Expression and transcriptional regulation of the human alpha3 neuronal nicotinic receptor subunit in T lymphocyte cell lines. J Neurochem 71: 1261-1270.
10. Benfante R, Flora A, Di Lascio S, Cargnin F, Longhi R, Colombo S et al. (2007). Transcription factor PHOX2A regulates the human a3 nicotinic receptor subunit gene promoter. J Biol Chem 282: 13290-13302.
11. Berrettini W, Yuan X, Tozzi F, Song K, Francks C, Chilcoat H et al. (2008). Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13: 368373.
12. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X, et al. (2008). Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165: 11631171.
13. Bigger CB, Melnikova IN, Gardner PD. (1997). Sp1 and Sp3 regulate expression of the neuronal nicotinic acetylcholine receptor b4 subunit gene. J Biol Chem 272: 2597625982.
14. Blanchet MR, Israel-Assayag E, Cormier Y. (2004). Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am J Respir Crit Care Med 169: 903909.
15. Boulter J, OShea-Greenfield A, Duvoisin RM, Connolly JG, Wada E, Jensen A., et al. (1990). Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J Biol Chem 265: 44724482.
16. Boyd RT. (1997). The molecular biology of neuronal nicotinic acetylcholine receptors. Crit Rev Toxicol 27: 299318.
17. Bruschweiler-Li L, Fuentes Medel YF, Scofield MD, Trang EBT, Binke SA, Gardner PD. (2010). Temporally- and spatially-regulated transcriptional activity of the nicotinic acetylcholine receptor b4 subunit gene promoter region. Neurosci 166: 864877.
18. Calabresi P, Lacey MG, North RA. (1989). Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol 98: 135140.
19. Campos-Caro A, Carrasco-Serrano C, Valor LM, Ballesta JJ, Criado M. (2001). Activity of the nicotinic acetylcholine receptor alpha5 and alpha7 subunit promoters in muscle cells. DNA Cell Biol 20:657666.
20. Campos-Caro A, Carrasco-Serrano C, Valor LM, Viniegra S, Ballesta JJ, Criado M. (1999). Multiple functional Sp1 domains in the minimal promoter region of the neuronal nicotinic receptor alpha5 subunit gene. J Biol Chem 274: 46934701.
21. Caporaso N, Gu F, Chatterjee N, Sheng-Chih J, Yu K, YeagerMet al. (2009). Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One 4: e4653.
22. CDC (2009). Cigarette Smoking among Adults and Trends in Smoking Cessation-United States, 2008. Centers for Disease Control and Prevention 58: 12271232.
23. Conklin BS, Zhao W, Zhong DS, Chen C. (2002). Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol 160: 413418.
24. Conti-Fine BM, Navaneetham D, Lei S, Maus AD. (2000). Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? Eur J Pharmacol 393: 279294.
25. Cooke JP, Ghebremariam YT. (2008). Endothelial nicotinic acetylcholine receptors and angiogenesis. Trends Cardiovasc Med 18: 247253.
26. Corrigall WA, Coen KM. (1991). Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology (Berl) 104: 171176.
27. Corrigall WA, Franklin KB, Coen KM, Clarke PB. (1992). The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107: 285289.
28. Corrigall WA, Herling S, Coen KM. (1989). Evidence for a behavioral deficit during withdrawal from chronic nicotine treatment. Pharmacol Biochem Behav 33: 559562.
29. Corringer PJ, Le Novere N, Changeux J-P. (2000). Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 40: 431458.
30. Corriveau RA, Berg DK. (1993). Coexpression of multiple acetylcholine receptor genes in neurons: quantification of transcripts during development. J Neurosci 13: 26622671.
31. Couturier S, Bertrand D, Matter JM, Hernandez MC, Bertrand S, Millar N et al. (1990). A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron 5: 847856.
32. Dani JA, Bertrand D. (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47: 699729.
33. Dani JA, De Biasi M. (2001). Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 70: 439-446.
34. Dasgupta P, Chellappan SP. (2006). Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 5: 2324-2328.
35. Davis R, Rizwani W, Banerjee S, Kovacs M, Haura E, Coppola D et al. (2009). Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 4: e7524.
36. De Biasi M, Salas R. (2008). Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal. Exp Biol Med 233: 917-929.
37. Di Chiara G. (2000). Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393: 295-314.
38. Di Chiara G, Imperato A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274-5278.
39. Du Q, Melnikova IN, Gardner PD. (1998). Differential effects of heterogeneous nuclear ribonucleoprotein K on Sp1- and Sp3-mediated transcriptional activation of a neuronal nicotinic acetyl-choline receptor promoter. J Biol Chem 273: 19877-19883.
40. Du Q, Tomkinson AE, Gardner PD. (1997). Transcriptional regulation of neuronal nicotinic acetylcholine receptor genes. A possible role for the DNA-binding protein Puralpha. J Biol Chem 272: 14990-14995.
41. Egleton RD, Brown KC, Dasgupta P. (2008). Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 29: 151-158.
42. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S. (1994). Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79: 705-715.
43. Elgoyhen AB, Vetter DE, Katz E, Rothlin CV, Heinemann SF, Boulter J. (2001) alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechan-osensory hair cells. Proc Natl Acad Sci USA 98 3501-3506